MNMichael E. Neufeld

Michael E. Neufeld

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael E. Neufeld has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical Outcomes and Survivorship After Conversion of Metal-on-Metal Hip Resurfacing to Total Hip Arthroplasty

    by Ali Lari, Ali Ashkanani, Mohammed Ashkanani, Lisa C. Howard, Warran Wignadasan, Bassam A. Masri, Donald S. Garbuz, Michael E. Neufeld

    Background: Hip resurfacing arthroplasty was developed for younger active patients to preserve bone stock and facilitate future revision; however, failure requiring conversion to total hip arthroplasty (THA) remains a recognized problem. Outcomes after conversion are variable and influenced by indication and technical factors. This systematic review evaluates survivorship, complications, and functional outcomes after conversion of hip resurfacing to THA. Methods: A systematic review was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and registered with International Prospective Register of Systematic Reviews. MEDLINE, Embase, Web of Science, and Cumulative Index to Nursing and Allied Health Literature were searched for studies reporting outcomes after revision of hip resurfacing to THA. Eighteen studies met inclusion criteria. Data were extracted on demographics, indications, revision strategy, complications, survivorship, and functional outcomes. Results: Nineteen studies comprising 1,698 patients and 1,719 hips were included. The mean age was 56.0 years, with mean time to conversion of 4.74 years and follow-up of 3.80 years. The most common indications were aseptic loosening (31.4%), adverse reaction to metal debris (ARMD) (27.1%), and femoral neck fracture (23.7%). Femoral only revision was performed in 36% and both components in 64%. The pooled complication rate was 10.5%, most commonly dislocation, infection, loosening, and ARMD. Survivorship ranged from 94.7% to 100% short term, 83.3% to 94.8% midterm, and 69% to 92% at 10 years, with up to 85.3% at 13 years, and was lower in ARMD. Functional outcomes improved, with mean Harris Hip Score increasing from 47.0 to 88.4. Conclusion: Conversion of failed hip resurfacing to THA provides consistent and clinically meaningful improvement in pain and function. However, complication rates remain substantial and long-term survivorship is variable and influenced by the indication for failure. Metal-related pathology and aseptic loosening were associated with less favorable outcomes than mechanically driven failures. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.


  • Injection-Based Therapies for the Management of Hip and Knee Osteoarthritis

    by K.T. Matthew Seah, Michael E. Neufeld, Lisa C. Howard, Donald S. Garbuz, Bassam A. Masri

    ➢ Corticosteroid injections are largely safe, but patients and practitioners should be aware of the small risk of adverse side effects, and their limited duration of efficacy. The timing of injection should be coordinated with potential surgical dates. ➢ The routine use of hyaluronic acid injections for osteoarthritis is not recommended, but there are certain subsets of patients, such as those who have undergone other therapies that failed, who may benefit from it. ➢ Local anesthetics are frequently used in conjunction with corticosteroids for enhanced pain control; however, caution is needed because of concerns regarding chondrotoxicity. Proper patient selection is crucial, and their overuse for diagnostic purposes is not recommended. ➢ There is currently insufficient evidence to support the routine use of prolotherapy, bone marrow aspirate concentrate, stromal vascular fraction, and mesenchymal stromal cell injections. ➢ Intra-articular saline solution has been associated with improvements in both patient-reported pain and function scores, and this should be considered in future study designs.


  • Metaphyseal Fixation in Revision Total Knee Arthroplasty

    by Panayiotis D. Megaloikonomos, Yasir AlShehri, Donald S. Garbuz, Lisa C. Howard, Michael E. Neufeld, Bassam A. Masri

    ➢ Bone defect management is challenging, but essential, in revision total knee arthroplasty. ➢ Appropriate metaphyseal fixation is crucial for stability and implant support. ➢ Allografts have been traditionally used to address large defects, but the advent of highly porous metaphyseal cones and sleeves has attracted attention during the past years. ➢ Metaphyseal implants are now available in a variety of shapes and sizes to meet various clinical needs. ➢ These devices can successfully fill large defects, can better support revision implants, and can achieve long-term biologic fixation. ➢ Very good intermediate-term outcomes have been reported with the available metaphyseal implants, using fully cemented or press-fit stems. ➢ More research is warranted to further assess surgical indications and the strengths and weaknesses of the various implants used for metaphyseal fixation.


  • Distal Femoral Replacement for Revision Total Knee Arthroplasty in Nononcologic Indications: A Single-Institution Outcomes Study

    by Arsh Sidhu, Lisa C. Howard, Jenny He, Nelson V. Greidanus, Bassam A. Masri, Donald S. Garbuz, Michael E. Neufeld


  • Short-term survival of the cementless triathlon total knee arthroplasty in a young patient cohort

    by Gerard A. Sheridan, Michael E. Neufeld, Lisa C. Howard, Donald S. Garbuz, Bassam A. Masri

    Background The purpose of this study is to assess the short-term survivorship of a new cementless total knee arthroplasty (TKA) design in comparison to its cemented predecessor design in a young patient cohort less than 65 years of age. Methods We performed a retrospective cohort study of all primary TKAs (cemented and cementless) in patients under the age of 65 at the time of the index procedure, in a single institution between May 2018 and May 2019. Primary outcome variables included aseptic revision and all-cause revision. Operative time was a secondary variable. Independent variables considered included age, sex, body mass index (BMI), American Society of Anesthesiologists (ASA) grade, implant type (cruciate-retaining (CR) or posterior-stabilised (PS)) and the use of cemented or cementless implants. Results There were 106 cemented TKAs and 152 cementless TKAs (Triathlon, Stryker Inc, Mahwah, NJ ) implanted. The minimum follow-up for all cases was 2 years (mean cementless 32.5 months, mean cemented 34.9 months). Of the entire 258 implants only 2 were revised. Both revisions occurred in the cemented cohort for prosthetic joint infection (PJI). The all-cause revision rate in the cementless cohort was 0% compared to 1.8% in the cemented cohort (p = 0.168). Operative times were significantly reduced from 62 min in the cemented cohort to 52.2 min in the cementless cohort (p < 0.001). Conclusion In a young patient cohort, the cementless Triathlon TKA demonstrates excellent survivorship at short-term follow-up with significant reductions in operative times when compared to the cemented Triathlon TKA.


  • Cementless Total Knee Arthroplasty

    by Yasir AlShehri, Panayiotis D. Megaloikonomos, Michael E. Neufeld, Lisa C. Howard, Nelson V. Greidanus, Donald S. Garbuz, Bassam A. Masri

    Update: This article was updated on August 23, 2024, because of a previous error. On page 1, the following footnote was omitted but has since been included: *Yasir AlShehri, MD, and Panayiotis D. Megaloikonomos, MD, contributed equally to this work as first authors. An erratum has been published: JBJS Rev. 2024;12(7):e24.00064ER. » The demographic profile of candidates for total knee arthroplasty (TKA) is shifting toward younger and more active individuals. » While cemented fixation remains the gold standard in TKA, the interest is growing in exploring cementless fixation as a potentially more durable alternative. » Advances in manufacturing technologies are enhancing the prospects for superior long-term biological fixation. » Current research indicates that intermediate to long-term outcomes of modern cementless TKA designs are comparable with traditional cemented designs. » The selection of appropriate patients is critical to the success of cementless fixation techniques in TKA. » There is a need for high-quality research to better understand the potential differences and relative benefits of cemented vs. cementless TKA systems.


  • Management of Reinfection After One-Stage Exchange Arthroplasty

    by Gerard A. Sheridan, Michael E. Neufeld, Andrea Volpin, Bassam A. Masri

  • The John Charnley Award: The Impact of Human Leukocyte Antigen Genotype on Bacterial Infection Rates and Successful Eradication in Total Hip Arthroplasty

    by Michael E. Neufeld, Gerard A. Sheridan, Tanya MacDonell, Lisa C. Howard, Bassam A. Masri, Paul Keown, Karen Sherwood, Donald S. Garbuz


  • The Wagner Cone Stem for Atypical Femoral Anatomy in Total Hip Arthroplasty

    by Babar Kayani, Michael E. Neufeld, Maria Bautista, Lisa C. Howard, Mohammed Abdelmalek, Nelson V. Greidanus, Bassam A. Masri, Donald S. Garbuz

    Background: The Wagner Cone Prosthesis was designed to address complex femoral deformities during total hip arthroplasty (THA), but its mid-term component survivorship and functional outcomes remain undetermined. The objectives of this study were to determine the implant survivorship, patient satisfaction, functional outcomes, osseointegration as seen radiographically, implant subsidence, and complications of THA using the Wagner Cone Prosthesis stem at intermediate-term follow-up. Methods: This study involved 302 patients with proximal femoral deformities, including developmental hip dysplasia and Legg-Calvé-Perthes disease, who underwent a total of 320 primary THAs using the Wagner Cone Prosthesis. The average age at the time of surgery was 49.4 ± 14.5 years (range, 18.8 to 85.6 years). Patient satisfaction was recorded using a self-administered questionnaire assessing satisfaction in 4 domains. The University of California at Los Angeles (UCLA) activity score, the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the Oxford Hip Score (OHS), the Forgotten Joint Score (FJS), radiographic outcomes, and complications were recorded. The mean follow-up time was 10.1 years (range, 5.2 to 15.5 years). Results: Survivorship of the Wagner Cone Prosthesis was 98.7% (95% confidence interval [CI]: 97.2% to 100%) with stem revision as the end point and 95.8% (95% CI: 93.5% to 98.2%) with reoperation for any reason as the end point at 10 years postoperatively. In total, 3 stems were revised: 2 for infection and 1 for chronic hip dislocation. The median patient satisfaction score was 95 (interquartile range [IQR], 80 to 100), median UCLA score was 6 (IQR, 6 to 7), median WOMAC score was 18 (IQR, 16 to 22), median OHS was 40 (IQR, 36 to 47), and median FJS was 80 (IQR, 76 to 88) at the time of final follow-up. All Wagner Cone stems that were not revised showed radiographic evidence of osseointegration, with a mean stem subsidence of 0.9 ± 0.8 mm at the most recent follow-up. Conclusions: The use of the Wagner Cone Prosthesis stem in patients with complex femoral anatomy undergoing primary THA is associated with excellent component survivorship, high levels of patient satisfaction, good functional outcomes, and reliable osseointegration with minimal stem subsidence as seen on radiographs at intermediate-term follow-up. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.